Zhang Jing, Zhang Hai, Cai Wenxian, Yu Leiping, Zhen Xuechu, Zhang Ao
Synthetic Organic and Medicinal Chemistry Laboratory (SOMCL), Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China.
Bioorg Med Chem. 2009 Jul 15;17(14):4873-80. doi: 10.1016/j.bmc.2009.06.019. Epub 2009 Jun 16.
A series of new 1-aryl-3-benzazepine derivatives containing an arylpiperazinyl function as the N3 substituent were synthesized by combining a D(1) receptor agonistic pharmacophore and a 5-HT(1A) receptor pharmacophore through Click reaction. Interestingly, these compounds generally do not have good binding affinity at the D(1) receptor, but most compounds are potent at both D(2) and 5-HT(1A) receptors. Compound 8h, containing 1-m-tolyl-benzazepine scaffold and 2-methoxyphenylpiperazine core, displayed good affinity at all tested receptors, with K(i) values of 144, 80, and 133nM, for the D(1), D(2), and 5-HT(1A) receptors, respectively. Compound 13 with the triazole moiety formed differently from that in 8h showed the highest affinity at the D(2) receptor with K(i) value of 19nM. This compound also showed moderate affinity at the 5-HT(1A) (K(i), 105nM), and D(1) (K(i), 551nM) receptors. Functional assays indicated that both compounds 13 and 8h are antagonists at D(1) and D(2) receptors, whereas full agonistic activity at the 5-HT(1A) receptor was observed. In agreement with the binding affinity, compound 13 is a high efficacy D(2) antagonist and 5-HT(1A) agonist.
通过点击反应将D(1)受体激动剂药效团和5-HT(1A)受体药效团结合,合成了一系列以芳基哌嗪基作为N3取代基的新型1-芳基-3-苯并氮杂卓衍生物。有趣的是,这些化合物通常在D(1)受体上没有良好的结合亲和力,但大多数化合物在D(2)和5-HT(1A)受体上具有活性。含有1-间甲苯基-苯并氮杂卓骨架和2-甲氧基苯基哌嗪核心的化合物8h在所有测试受体上均表现出良好的亲和力,其对D(1)、D(2)和5-HT(1A)受体的K(i)值分别为144、80和133 nM。具有与8h中不同形成方式的三唑部分的化合物13在D(2)受体上表现出最高亲和力,K(i)值为19 nM。该化合物在5-HT(1A)(K(i),105 nM)和D(1)(K(i),551 nM)受体上也表现出中等亲和力。功能测定表明,化合物13和8h在D(1)和D(2)受体上均为拮抗剂,而在5-HT(1A)受体上观察到完全激动活性。与结合亲和力一致,化合物13是一种高效的D(2)拮抗剂和5-HT(1A)激动剂。